Pure and Organic CBD & and Hemp Products

Effective medicine provided by mother nature

  • Powerful relaxant

  • Strong painkiller

  • Stress reduction
  • Energy booster

Why CBD?

More and more renowned scientists worldwide publish their researches on the favorable impact of CBD on the human body. Not only does this natural compound deal with physical symptoms, but also it helps with emotional disorders. Distinctly positive results with no side effects make CBD products nothing but a phenomenal success.

This organic product helps cope with:

  • Tight muscles
  • Joint pain
  • Stress and anxiety
  • Depression
  • Sleep disorder

Range of Products

We have created a range of products so you can pick the most convenient ones depending on your needs and likes.

CBD Capsules Morning/Day/Night:

CBD Capsules

These capsules increase the energy level as you fight stress and sleep disorder. Only 1-2 capsules every day with your supplements will help you address fatigue and anxiety and improve your overall state of health.

Order Now

CBD Tincture

CBD Tincture

No more muscle tension, joints inflammation and backache with this easy-to-use dropper. Combined with coconut oil, CBD Tincture purifies the body and relieves pain. And the bottle is of such a convenient size that you can always take it with you.

Order Now

Pure CBD Freeze

Pure CBD Freeze

Even the most excruciating pain can be dealt with the help of this effective natural CBD-freeze. Once applied on the skin, this product will localize the pain without ever getting into the bloodstream.

Order Now

Pure CBD Lotion

Pure CBD Lotion

This lotion offers you multiple advantages. First, it moisturizes the skin to make elastic. And second, it takes care of the inflammation and pain. Coconut oil and Shia butter is extremely beneficial for the health and beauty of your skin.

Order Now

Wholesale CBD Oil Distributors | Tree of Life Botanicals

Fibromyalgia Survey Results 2014



  • Fibromyalgia Survey Results 2014
  • Marijuana Rated Most Effective for Treating Fibromyalgia
  • Associated Data
  • Revisions to the / fibromyalgia diagnostic criteria. (1)National Data Bank for Rheumatic Diseases, N Emporia, Ste , Wichita, KS ; for survey and clinical research are widely used for fibromyalgia diagnosis. Results. Fibromyalgia survey scores ranged from 0– The cohort was old) undergoing shoulder arthroscopy between August and January were . The guidelines were developed by the Canadian Fibromyalgia .. The German guidelines recommended the use of the fibromyalgia survey questionnaire Material online at online-casino-player.info).

    Fibromyalgia Survey Results 2014

    Most importantly, other functional somatic syndromes e. A tender point examination is not obligatory for the diagnosis of FMS. This physical finding, subject to variable interpretation and which reflects an overall reduction in pain threshold, has at times been inappropriately used to establish a diagnosis of FMS. Excessive healthcare utilization with referral to multiple specialists and repeated radiographic and laboratory investigations should be discouraged. The use of the modified ACR diagnostic criteria [ 4 , 28 ], which do not require tender point examination, is recommended for clinical diagnosis, but should not preclude a thorough physical examination.

    While some patients with FMS will still be referred to rheumatologists, mostly to exclude some other rheumatic condition, FMS should no longer be identified as an exclusive rheumatic syndrome. This reinforces the true existence and validity of a condition that has caused so much consternation over the years. The concept of FMS, however, remains a work in progress with many current unanswered clinical and pathophysiologic questions.

    These recent guidelines as well as the revision of criteria for the diagnosis of FMS are clearly steps towards a better understanding of this condition. The ACR criteria will also likely lead to higher rates of FMS diagnosis in men because healthy [ 31 ] as well as men diagnosed with FMS [ 32 ] have less tender points than women.

    FMS, often disputed and challenged, has emerged as a clinical syndrome with a clear cluster of symptoms and comorbidities. Despite the ongoing paucity of biomarkers available for diagnosing and monitoring of this condition, a systematic evidence-based approach can lead to effective, patient-centered management with avoidance of unnecessary and harmful interventions.

    The cluster of symptoms that we today recognize as FMS has been described in the literature for over years, with the specific diagnostic label of FMS introduced at the end of the 20th century [ 33 ].

    The recent evidence-based interdisciplinary guidelines developed in Canada, Germany, and Israel should give healthcare professionals confidence to positively diagnose this condition, avoid excessive testing and medical consultation, and facilitate patient care by emphasis on appropriate patient education and active patient participation in healthcare plan. Fibromyalgia Survey Questionnaire Polysymptomatic Distress Scale contanis the symptom severity score and the widespread pain index.

    Howard Amital has no conflict of interests to declare. National Center for Biotechnology Information , U. Evid Based Complement Alternat Med. Published online Nov Dan Buskila 4 Department of Medicine, H.

    Author information Article notes Copyright and License information Disclaimer. Received Apr 9; Accepted Oct 1. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

    This article has been cited by other articles in PMC. Associated Data Supplementary Materials Fibromyalgia Survey Questionnaire Polysymptomatic Distress Scale contanis the symptom severity score and the widespread pain index.

    Materials and Methods 2. Inclusion Criteria To be included in our analysis, the guidelines had to meet the following criteria. The guideline was commissioned by a scientific organisation. The guideline group was interdisciplinary and included at least the specialties rheumatology, pain medicine, and psychiatry or psychosomatic medicine or clinical psychology.

    The formal process for establishing recommendations Delphi exercise, panel conference was outlined. Table 1 Comparison of the composition of the guideline groups and the funding of the Canadian, German, and Israeli guidelines.

    Open in a separate window. Methodologies Details of the composition of the methodologies to design levels of evidence and grades of recommendations are outlined in Table 2. Table 2 Comparison of the methodology of the Canadian, German, and Israeli guidelines.

    Table 3 Comparison of the categorisation of evidence treatment and recommendations of the Canadian, German, and Israeli guidelines. Need for a Guideline All three countries justified the need for development of guidelines on the basis of the high prevalence of FMS and the association of reduced health-related quality of life of patients and high healthcare costs as well as controversies surrounding diagnosis and management [ 10 , 11 , 20 ]. Recommendations for Definition and Classification Recommendations concerning the definition, classification, clinical diagnosis, and general principles of care set out by all three guidelines were predominantly based on expert consensus, with very limited evidence available in the current literature.

    Recommendations for Clinical Diagnosis Details of the recommended diagnostic workup are outlined in Table 4. The symptoms are not caused by an organic disease such as abnormality of muscles or joints but are instead based on a functional disorder. The goals of treatment are improvement in quality of life, maintenance of function functional ability in everyday situations , and reduction of symptoms.

    The ability of the patient to modulate symptoms via self-management strategies should be emphasized [ 11 ]. Discussion We have identified considerable consistency between three recently published FMS guidelines spanning three continents.

    Conclusions FMS, often disputed and challenged, has emerged as a clinical syndrome with a clear cluster of symptoms and comorbidities. Supplementary Material Fibromyalgia Survey Questionnaire Polysymptomatic Distress Scale contanis the symptom severity score and the widespread pain index Click here for additional data file. The American College of Rheumatology Criteria for the classification of Fibromyalgia.

    Report of the Multicenter Criteria Committee. Seminars in Arthritis and Rheumatism. Prevalence of Fibromyalgia in the Israeli population: Fibromyalgia criteria and severity scales for clinical and epidemiological studies: Fibromyalgia prevalence, somatic symptom reporting, and the dimensionality of polysymptomatic distress: What are the key symptoms of Fibromyalgia?

    Results of a survey of the German Fibromyalgia Association. The comparative economic burden of mild, moderate, and severe Fibromyalgia: Journal of Managed Care Pharmacy. Harth M, Nielson WR. The Fibromyalgia tender points: A brief review of the controversy. Methodological fundamentals of the development of the guideline. General principles and coordination of clinical care and patient education.

    Definition, classification, clinical diagnosis and prognosis. Psychotherapy for patients with Fibromyalgia syndrome. Systematic review, meta-analysis and guideline. To correct for possible overfitting and to have an unbiased assessment of the model's predictive performance, regularized variable selection was done using adaptive LASSO and the Bayesian Information Criterion BIC.

    A total of patients were assessed for eligibility. Fifty-three patients were excluded for the following reasons: The remaining patients were approached. Three patients did not receive nerve blocks, as per the anesthesiologist's decision in the operating room, and were excluded from the study.

    Another two patients withdrew prior to POD 2: Three patients could not be reached for postoperative follow-ups Figure 1. The numbers of eligible, excluded, approached, declined, and consented patients are shown. All consented patients completed baseline phenotyping assessments. After surgery, 8 patients were excluded for various reasons, and the assessment of acute pain outcomes was performed in 92 patients.

    Fibromyalgia survey scores ranged from 0—13, out of a maximum of 31 Figure 2 ; mean [SD]: Distribution of fibromyalgia survey scores. In this patient population, fibromyalgia survey scores ranged from 0 to 13, out of a maximum of There were no significant differences in age Table 1. Neuropathic pain scores were significantly different between very-low and low or moderate groups. Few patients took opioids prior to surgery, as patients with chronic opioid use defined as daily use of any opioid for 5 of the 7 days prior to surgery were excluded from the study, and preoperative opioid use was not significantly different between groups Table 1.

    Lower results on preoperative physical functioning and quality of recovery scores were also associated with increases in fibromyalgia survey scores, and significant differences among groups were observed Table 1. In addition, significant increases between groups were observed for catastrophizing 0— Furthermore, no differences in surgery type or anesthesia type were observed between the three tertiles of fibromyalgia survey scores.

    The primary outcome of opioid consumption was assessed on POD 2. No differences in opioid consumption were observed between the three tertiles of fibromyalgia survey scores Table 2. There were also no differences in the self-reported duration of the nerve block.

    No significant differences in pain severity scores were observed between groups. There were significant differences in physical function on POD 2, but the differences in quality of recovery and neuropathic pain were not significant in univariate analyses. On POD 14, however, there was an association of increased opioid consumption with higher fibromyalgia survey scores. At this time point, opioid consumption was much higher in the low group than in the very-low group.

    A multivariate linear mixed model including all of the preoperative measures was used to determine characteristics independently associated with postoperative opioid consumption. Preoperative opioid use was associated with increased postoperative opioid consumption. As expected, the POD 14 time point was also associated with increased post-operative opioid consumption. No other associations were found Table 3.

    Similar multivariate linear mixed models were used to determine independent predictors of other postoperative outcomes. In particular, the fibromyalgia survey score was independently associated with poorer overall recovery, as measured by the change in quality of recovery score from baseline to POD 2. Preoperative opioid use and male sex were also independently associated with poorer recovery Table 4.

    Regularized variable selection yielded a model with inferior BIC Model diagnostics was done using standardized residual plots and did not reveal any violation of model assumptions. Although the study was underpowered to robustly analyze individual item level data from the quality of recovery questionnaire, each item was assessed individually.

    This is the first study to examine whether the preoperative pain history, along with the fibromyalgia survey tool, could predict postoperative pain outcomes in shoulder arthroscopy patients. Higher fibromyalgia survey scores were not independently associated with postoperative opioid consumption in this patient population. Although the primary outcome was negative, lower preoperative fibromyalgia survey scores were independently associated with increased postoperative quality of recovery scores.

    Shoulder surgeries are commonly performed to treat musculoskeletal pain. As was seen in the present study, the fibromyalgia survey score was recently shown to be associated with a worse preoperative pain phenotype in lower-extremity joint replacement patients.

    This led to the hypothesis that the fibromyalgia survey score may predict postoperative pain outcomes in other cohorts. Shoulder arthroscopic surgeries can potentially result in moderate-to-severe pain,[ 1 , 23 ] although they are less invasive than lower-extremity joint replacement surgeries. On POD 2, the lowest tertile of fibromyalgia survey scores had significantly better physical function when compared to the other groups, as well as non-significant trends in lower opioid consumption, pain scores, and neuropathic pain.

    In multivariate modeling, the only outcome measure that correlated with the continuous fibromyalgia score was the change in the quality of recovery scale. The specific components of this scale that were independently associated with the fibromyalgia survey score were the incidence of headaches, backaches, or muscle pains.

    The quality of recovery questionnaire has been used to evaluate post-surgical and post-anesthetic recovery. The fibromyalgia survey scores in our cohort ranged from 0 to 13 with a mean score of 5. In this population, with fibromyalgia survey scores that were overall low and in a relatively narrow range, the scores were not independent predictors of postoperative pain.

    Furthermore, this range was substantially narrower than that reported in lower-extremity joint arthroplasty patients, in which the mean score was 6. Another distinguishing feature of the cohort in this study was the exclusion of patients chronically taking opioids preoperatively. Whereas preoperative opioid use was similarly predictive of increased postoperative opioid use, the fibromyalgia survey score predicted additional variance.

    In the present study, patients in the low fibromyalgia group consumed more opioids postoperatively and had higher pain scores than patients in the very-low fibromyalgia survey score group on POD It is therefore possible that the moderate use of opioids in the low group confounded the outcomes with respect to the fibromyalgia survey score.

    Patients in the highest fibromyalgia tertile were also more likely to have had surgery that was deemed less painful, although this was not significant.

    Although the fibromyalgia survey score did not appear to predict postoperative pain outcomes, there are several strengths of this study. It is the first to assess fibromyalgia survey scores in shoulder arthroscopy patients, and the outcomes data were collected prospectively. I have come to the conclusion after many years of pain from several conditions that a miracle is required. As I believe in God and am a Christian I have decided to pray, fast and seek counsel, you see my life is truly in the hands of God, and God says, we are to seek him and not be double minded, in other words, believe one day for healing and then get all doubtful and say, no, God will not heal.

    Globally miracles happen all the time, I believe it is better to put my life in the hands of God who made me, then to take medication that turns me into an addict or gives me serious side effects, Pills or God is the choice I have chosen mine. I live in a medical marijuana state. I started medical marijuana over 9 weeks ago.

    I also use CBD drops nightly. All I can say is that my pain has been reduced significantly that it is almost non existent. I have suffered for 27 years. I have tried most of these pharmaceuticals…Lyrica has worked for me for the past 8 years.

    Cannabis is the best for my pain and mood. I use it so regularly that I am functional….. For the person asking for strains…. Sativa works well for me during the day. It is mood elevating which helps with the depression and chronic fatigue as well as the pain. At night, I use Honey Pot which is Indica infused bee honey.

    Sleep like a baby. This survey is hardly scientific. If medical marijuana can really help fibromyalgia, then the arguments need to be backed up with solid science rather than a loaded question. This only harms our cause. I have suffered for many years from pain that worsened after three surgery.

    I would tell my GP. The pain is constant the depression the anxiety no sleep migraines to touch my skin hurts this is a horrible disorder of the body. I have not tried the pharmasuticals But I do know the best way for me to be able to get up and function is Marijuana. I have my best days when I have it. I have weaned my self off of Topamax,feoricet, lexapro,estadol,and xannex all in the last 2months it has been very hard but at least my organs are functioning better. It requires a larger dose to knock the pain down significantly which I reserve for use before going to bed because that allows me to get restful, restorative sleep and many times I awake feeling refreshed — something no known prescription medication can accomplish.

    I am richly blessed to live in Oregon, and one of the reasons is the attitude toward medical mj. However, I asked my Dr over a year ago about it. I do feel for those of you who would be thrown in jail if you were caught with decent pain medication. God bless us all. I had cancer and sinc then have suffered from fibro. My oncologist would be willing to write the script, or whatever they do, to help me with this horrible pain but I need something that will NOT get me high..

    Just make the pain go away… Do the oils or any of the other forms do this? I just want my life back! I thankfully live in Colorado where Medical Marijuana is legal. It helps so much for so many symptoms! For pain, use CBD strain and indica is by far the best way to go. It truly is the best pain reliever amongst other things and all natural instead of narcotics! The problem is I live in New Jersey and our medical marijuana program is essentially a sham.

    Chronic pain is not on the approved disease list and even the people whose disease are on the list cannot seem to even get any. So, people like me who suffer with this horrible disease who have found something that actually helps to take the pain away and regain some sort of normalcy once again are screwed because we have no access to it legally.

    Marijuana Rated Most Effective for Treating Fibromyalgia

    () revision to the / fibromyalgia criteria. Fibromyalgia may now be . included data from surveys that assessed the prevalence of fibromyalgia in. In June, we developed and posted the Access to Pain Medication Survey on Survey Monkey. A total of 5, respondents with either fibromyalgia or other . sis, and Lyme serology test results were all unremarkable. Her eryth- JAMA. ;(15) doi/jama Author Video . The alternative fibromyalgia survey criteria were in- tended for use.

    Associated Data



    () revision to the / fibromyalgia criteria. Fibromyalgia may now be . included data from surveys that assessed the prevalence of fibromyalgia in.


    In June, we developed and posted the Access to Pain Medication Survey on Survey Monkey. A total of 5, respondents with either fibromyalgia or other .


    sis, and Lyme serology test results were all unremarkable. Her eryth- JAMA. ;(15) doi/jama Author Video . The alternative fibromyalgia survey criteria were in- tended for use.


    Survey results showed the 10 most common factors perceived Fibromyalgia Impact Questionnaire . diagnosis as a somatic symptom disorder (Bass ).


    Thus, in this data set, the WPI alone provided the best diagnostic (PLI) and the 10 symptoms from the Symptom Impact Questionnaire (SIQR) is shown. The alternative criteria for diagnosing fibromyalgia.


    Volume 42, No, October Pages These changes result in the intensity of usually non-painful stimuli being amplified and experienced as painful. In an internet survey of 2 fibromyalgia patients in North America, 79%.

    Add Comment